Sperm DNA fragmentation testing: Methods, reliability, and clinical relevance
When it comes to assessing male fertility, most people are familiar with a semen analysis looking at sperm count, motility, and morphology. But these measures don't tell the whole story and are not truly predictive of male fertility, in fact even according to WHO criteria, a semen analysis is subjective and susceptible to numerous errors (Esteves, 2014; Wang & Swerdloff, 2014; Douglas et al., 2021; Sanyal et al., 2023). Therefore, clinicians and scientists are increasingly looking at other parameters including sperm DNA fragmentation, a critical factor that can affect fertility even when semen parameters appear normal (Repalle et al., 2022; Sugihara et al., 2022; Wang et al., 2023; Stavros et al., 2024).
DNA fragmentation tests evaluate the integrity of genetic material in sperm, a key component for successful fertilisation, healthy embryo development, and even live birth outcomes. In this article, we’ll explore the most widely used DNA fragmentation tests, discuss their differences, and help patients understand when and why one might be chosen over another.
What is sperm DNA fragmentation?
DNA fragmentation refers to the presence of breaks or irregularities in the genetic material within a sperm cell. This damage can occur during sperm production (spermatogenesis), whilst sperm are stored in the epididymis or during the process of ejaculation.
The damage can result from:
• Oxidative stress
• Environmental toxins
• Heat exposure
• Infections
• Varicoceles
• Ageing
• Lifestyle factors (e.g., smoking, poor diet, hot baths, excessive cycling)
• Radiation (X-rays, cell phones in the pocket etc.)
High levels of fragmentation are associated with:
• Poor embryo quality
• Implantation failure
• Miscarriage
• Lower success rates in IVF/ICSI cycles
That’s why understanding and accurately measuring DNA fragmentation has become a vital tool in diagnosing and managing male infertility.
When should you consider a DNA fragmentation test?
Sperm DNA fragmentation testing isn’t always the first step in fertility assessments but in certain situations, it can offer vital insights that a standard semen analysis can’t.
If you're facing ongoing challenges in your fertility journey, this type of testing may help uncover hidden issues that affect embryo development, implantation, or pregnancy success.
You may want to consider a sperm DNA fragmentation test if:
• You’ve had multiple IVF or ICSI failures - Even if fertilisation has occurred, embryos may fail to implant or develop due to compromised sperm DNA integrity. A fragmentation test can help identify if this is a factor.
• You’ve experienced recurrent miscarriage - Repeated pregnancy loss especially when other causes have been ruled out can sometimes be linked to damaged sperm DNA contributing to embryo failure.
• You’ve been told you have unexplained infertility - If standard fertility tests come back normal, but pregnancy still isn’t happening, a fragmentation test can uncover issues that would otherwise go undetected.
• You’re over the age of 40 - As men age, the likelihood of sperm DNA damage increases, even if other semen parameters remain within normal ranges.
• You have lifestyle or environmental risk factors - Smoking, high alcohol intake, obesity, chronic stress, poor diet, pollution, or frequent heat exposure (like hot baths or laptops on the lap) can all increase DNA damage.
• You have a varicocele - Varicoceles, enlarged veins in the scrotum, can lead to elevated scrotal temperatures and oxidative stress, both of which are linked to DNA fragmentation.
• You’ve had previous infections or medical treatments - Infections in the reproductive tract, fevers, or exposure to certain medications (including chemotherapy) can all increase DNA damage in sperm.
• You’ve experienced testicular surgery or trauma - Physical injury or surgical history affecting the testicles can compromise sperm DNA integrity.
In these situations, DNA fragmentation testing could help clarify next steps, guide treatment planning, or highlight opportunities to improve sperm quality before pursuing fertility treatment (Çağlayan et al., 2022; Repalle et al., 2022; Sugihara et al., 2022; Wang et al., 2023; Stavros et al., 2024).
Why lab quality is non-negotiable
The reliability of any DNA fragmentation result is heavily dependent on the environment in which it is processed. Because these tests involve delicate chemical and physical manipulation of sperm, laboratory accreditation and validation are essential.
A validated lab ensures that processes from cryopreservation to analysis are standardised. Without these rigorous quality management systems, results can be inconsistent which could have a significant impact on your fertility journey and treatment choices.
Clinical reasoning – Choosing the right methodology
Not all sperm DNA fragmentation tests are the same. The choice of test is often dictated by the specific clinical question a specialist is trying to answer based on the history and information from the patient.
Here is how the leading methodologies provide different layers of insight.
SCSA (Sperm Chromatin Structure Assay)
How it works:
For the SCSA, the sperm DNA is denatured by an acid. The DNA is then stained with a dye which reacts differently depending on whether the DNA is intact or fragmented. The analysis is done using flow cytometry to assess the susceptibility of sperm DNA to acid-induced denaturation. This has the advantage that a large number of sperm (usually 5,000 to 10,000) can be analysed in a relatively short period of time. The system is automated and is therefore eliminating subjectivity. The test measures both single- and double-strand DNA breaks giving a result of total sperm DNA fragmentation. The result is expressed as a percentage of sperm with fragmented or damaged DNA.
TUNEL – Terminal deoxynucleotidyl transferase dUTP nick end labelling
How it works:
TUNEL labels broken DNA strands directly with fluorescent markers and is visualised using light microscopy, fluorescence microscopy or with flow cytometry. When microscopic techniques are employed, only a relatively small number of sperm (usually 200 to 500) is evaluated, whereas using flowcytometry 5,000 to 10,000 sperm are analysed. Like the SCSA, the TUNEL assay measures both single- and double-strand DNA breaks and gives a total DNA fragmentation result. The result is expressed as a percentage of sperm with fragmented or damaged DNA.
COMET Test – Single Cell Gel Electrophoresis (Examen)
How it works:
Sperm are suspended in an agarose gel, spread on a microscopic slide and exposed to an electric field. If the DNA is damaged, the small DNA fragments move out of the nucleus and form a "comet tail" visible under a microscope. The longer the tail, the more damage. Depending on which type of the COMET assay, neutral or alkaline, is used, the test measures real and potential DNA damage, respectively. The COMET assay measures total DNA fragmentation (Exact®) and is also able to distinguish between single- and double-strand breaks (Extend®) of the DNA. While single-strand breaks can be repaired by the oocyte, this is harder, if not impossible, for double-strand breaks. The type of breaks is also significant in terms of the follow up with the patient.
SCD – Sperm Chromatin Dispersion Test (branded version HALO)
How it works:
Similar to the SCSA, this test uses a chemical process to denature sperm DNA. The samples is then suspended in an agarose gel on a microscopic slide and incubated. If the DNA is intact, a "halo" forms around the sperm nucleus. Damaged DNA prevents halo formation, indicating fragmentation. A relatively small number of sperm (usually 200 to 500) is microscopically evaluated.
While accessible, it is generally considered less robust than SCSA or Comet due to its subjective nature. Because it relies on a technician's visual interpretation, there is higher potential for variability between labs. Consequently, it is often used for basic screening rather than for making major clinical or surgical decisions.
Choosing the right test
With multiple testing options available there can be some confusion as to which test is most suitable. The truth is, there’s no one-size-fits-all answer. The right test depends on your medical history, fertility journey, and what your clinician needs the test to tell them.
What should you do after receiving your DNA fragmentation results?
Getting the results of a sperm DNA fragmentation test can be both illuminating and overwhelming. Whether your result shows high, moderate, or low fragmentation, what you do next matters more than the number itself.
High DNA fragmentation doesn't mean you're infertile, but it is a sign that something is interfering with sperm quality. It’s not necessarily a permanent state but the correct investigations and treatment are important.
Your next move should be a consultation with a male fertility specialist (an andrologist or urologist). They can help:
• Interpret your result in the context of your overall fertility profile
• Identify and treat possible underlying causes
• Guide you through diagnostic follow-ups
A common misconception is that ICSI (Intracytoplasmic Sperm Injection) is a direct solution for DNA fragmentation. While ICSI helps with fertilisation, it does not "repair" the DNA itself. If the injected sperm has high fragmentation, the risk of poor embryo quality and miscarriage remains.
Instead, a high result should lead to a targeted investigation of the root cause. This may include:
• Medical Treatment: Addressing infections or surgical correction of a varicocele.
• Lifestyle Shifts: Reducing oxidative stress through antioxidant therapy and the avoidance of heat/toxins.
• Refined ART Strategy: Using specific sperm selection techniques or adjusting abstinence periods.
After 3–6 months (and in some cases longer) of targeted intervention, you may be advised to repeat the DNA fragmentation test. Sperm quality can change with time, lifestyle adjustments, and even the season. So, it’s important to measure progress objectively.
Once you’ve taken steps to improve your sperm quality and retested, your male fertility specialist will advise on further steps, this may be to continue to try naturally or to move to IVF with or without ICSI.
At this point, if fertility treatment is still needed, you can enter it with greater confidence that you’ve optimised your sperm health which may improve success rates, reduce costs, and protect your emotional wellbeing.
DNA fragmentation isn’t the end of the road, it’s a signpost. With the right investigation, guidance, and support, many men are able to improve their sperm DNA potentially allowing them to conceive naturally or successfully conceive with less invasive treatment.
Conclusion
Sperm DNA fragmentation testing has moved the field of andrology toward a more personalised approach. Whether a clinician utilises the SCSA for its standardised, automated precision or the Comet test for its deep sensitivity into double-strand breaks, both represent the gold standard in modern diagnostics.
Ultimately, the choice of test should not be about which is "better," but which is most appropriate based on the patient's history. By working with accredited labs and fertility specialists, patients can ensure their treatment plan is built on a foundation of reliable, validated data.
References
Agarwal A, Farkouh A, Saleh R, Hamoda TAAAM, Salvio G, Boitrelle F, Harraz AM, Ghayda RA, Kavoussi P, Gül M, Toprak T, Russo GI, Durairajanayagam D, Rambhatla A, Birowo P, Cannarella R, Phuoc NHV, Zini A, Arafa M, Wyns C, Tremellen K, Sarıkaya S, Lewis S, Evenson DP, Ko E, Calogero AE, Bahar F, Martínez M, Ambar RF, Colpi GM, Bakircioglu ME, Henkel R, Kandil H, Serefoglu EC, Alfakhri A, Tsujimura A, Kheradmand A, Marino A, Adamyan A, Zilaitiene B, Ozer C, Pescatori E, Vogiatzi P, Busetto GM, Balercia G, Elbardisi H, Akhavizadegan H, Sajadi H, Taniguchi H, Park HJ, Maldonado Rosas I, Al-Marhoon M, Gilani MAS, Alhathal N, Quang N, Pinggera GM, Kothari P, Micic S, Homa S, Long TQT, Zohdy W, Atmoko W, Ibrahim W, Sabbaghian M, Abumelha SM, Chung E, Ugur MR, Ozkent MS, Selim O, Darbandi M, Fukuhara S, Jamali M, de la Rosette J, Kuroda S, Smith RP, Baser A, Kalkanli A, Tadros NN, Aydos K, Mierzwa TC, Khalafalla K, Malhotra V, Moussa M, Finocchi F, Rachman RI, Giulioni C, Avidor-Reiss T, Kahraman O, Çeker G, Zenoaga-Barbăroşie C, Barrett TL, Yilmaz M, Kadioglu A, Jindal S, Omran H, Bocu K, Karthikeyan VS, Franco G, Solorzano JF, Vishwakarma RB, Arianto E, Garrido N, Jain D, Gherabi N, Sokolakis I, Palani A, Calik G, Kulaksiz D, Simanaviciene V, Simopoulou M, Güngör ND, Blecher G, Falcone M, Jezek D, Preto M, Amar E, Le TV, Ahn ST, Rezano A, Singh A, Rocco L, Savira M, Rajmil O, Darbandi S, Sogutdelen E, Boeri L, Hernández G, Hakim L, Morimoto Y, Japari A, Sofikitis N, Altay B, Mahmutoglu AM, Al Hashimi M, Ziouziou I, Anagnostopoulou C, Lin H, Shah R (2024); Technical aspects and clinical limitations of sperm DNA fragmentation testing in male infertility: A global survey, current guidelines, and expert recommendations. World J Mens Health 42: 202-215
Douglas C, Parekh N, Kahn LG, Henkel R, Agarwal A (2021); A novel approach to improving the reliability of manual semen analysis: A paradigm shift in the workup of infertile men. World J Mens Health 39: 172-185
Esteves SC (2014); Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination. Int Braz J Urol 40: 443-453
Repalle D, Saritha KV, Bhandari S (2022); Sperm DNA fragmentation negatively influences the cumulative live birth rate in the intracytoplasmic sperm injection cycles of couples with unexplained infertility. Clin Exp Reprod Med 49(3): 185-195
Sanyal D, Arya D, Nishi K, Balasinor N, Singh D (2023); Clinical utility of sperm function tests in predicting male fertility: A systematic review. Reprod Sci 31: 863-882
Stavros S, Potiris A, Molopodi E, Mavrogianni D, Zikopoulos Z, Louis K, Karampitsakos T, Nazou E, Sioutis D, Christodoulaki C, Skentou C, Gerede A, Zachariou A, Christopoulos P, Panagopoulos P, Domali E, Drakakis P (2024); Sperm DNA fragmentation: Unraveling its imperative impact on male infertility based on recent evidence. Int J Mol Sci 25(18): 10167
Sugihara A, Punjabi U, Roelant E, De Neubourg D (2022); Is there a relationship between sperm DNA fragmentation and intra-uterine insemination outcome in couples with unexplained or mild male infertility? Results from the ID-Trial. Life (Basel) 13(1): 11
Wang C, Swerdloff RS (2014); Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests. Fertil Steril 102: 1502-1507
Wang Q, Gu X, Chen Y, Yu M, Peng L, Zhong S, Wang X, Lv J (2023); The effect of sperm DNA fragmentation on in vitro fertilization outcomes of unexplained infertility. Clinics (Sao Paulo) 78: 100261
